المؤلفون: Patil, S, Tamirat, M, Khazhidinov, K, Ardizzoni, E, Atger, M, Austin, A, Baudin, E, Bekhit, M, Bektasov, S, Berikova, E, Bonnet, M, Caboclo, R, Chaudhry, M, Chavan, V, Cloez, S, Coit, J, Coutisson, S, Dakenova, Z, De Jong, B, Delifer, C, Demaisons, S, Do, J, Dos Santos Tozzi, D, Ducher, V, Ferlazzo, G, Gouillou, M, Khan, U, Kunda, M, Lachenal, N, LaHood, A, Lecca, L, Mazmanian, M, McIlleron, H, Moreau, M, Moschioni, M, Nahid, P, Osso, E, Oyewusi, L, Panda, S, Pâquet, A, Thuong Huu, P, Pichon, L, Rich, M, Rupasinghe, P, Salahuddin, N, Sanchez Garavito, E, Seung, K, Velásquez, G, Vallet, M, Varaine, F, Yuya-Septoh, F, Mitnick, C, Guglielmetti, L

المصدر: Trials. 24(1)

مصطلحات موضوعية: Bedaquiline, Clofazimine, Delamanid, Fluroquinolone-resistant, Linezolid, MDR-TB, Multidrug-resistant, Non-inferiority, Pre-XDR TB, RR-TB, Rifampicin-resistant, Stratified medicine, Treatment shortening, Tuberculosis, Humans, Extensively Drug-Resistant Tuberculosis, Fluoroquinolones, Clofazimine, Linezolid, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Randomized Controlled Trials as Topic, Clinical Trials, Phase III as Topic

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/77z3m917Test

المؤلفون: Guglielmetti, L, Ardizzoni, E, Atger, M, Baudin, E, Berikova, E, Bonnet, M, Chang, E, Cloez, S, Coit, JM, Cox, V, de Jong, BC, Delifer, C, Do, JM, Tozzi, D Dos Santos, Ducher, V, Ferlazzo, G, Gouillou, M, Khan, A, Khan, U, Lachenal, N, LaHood, AN, Lecca, L, Mazmanian, M, McIlleron, H, Moschioni, M, O’Brien, K, Okunbor, O, Oyewusi, L, Panda, S, Patil, SB, Phillips, PPJ, Pichon, L, Rupasinghe, P, Rich, ML, Saluhuddin, N, Seung, KJ, Tamirat, M, Trippa, L, Cellamare, M, Velásquez, GE, Wasserman, S, Zimetbaum, PJ, Varaine, F, Mitnick, CD

المصدر: Trials. 22(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Antimicrobial Resistance, Biodefense, Rare Diseases, Clinical Trials and Supportive Activities, Orphan Drug, Infectious Diseases, Prevention, Emerging Infectious Diseases, Tuberculosis, Lung, Clinical Research, Vaccine Related, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Infection, Good Health and Well Being, Antitubercular Agents, Bayes Theorem, Humans, Pharmaceutical Preparations, Randomized Controlled Trials as Topic, Rifampin, Tuberculosis, Multidrug-Resistant, Rifampin-resistant tuberculosis, Rifampicin-resistant tuberculosis, Bedaquiline, Delamanid, Linezolid, Clofazimine, Fluoroquinolone, Pyrazinamide, Treatment shortening, MDR-TB, Non-inferiority, Bayesian adaptive randomization, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, General & Internal Medicine, Clinical sciences, Epidemiology, Health services and systems

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/7fb6h2xdTest

المؤلفون: Patil, S, B, Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J., Coutisson, S., Dakenova, Z., de Jong, B, C, Delifer, C., Demaisons, S., Do, J, M, dos Santos Tozzi, D., Ducher, V., Ferlazzo, G., Gouillou, M., Khan, U., Kunda, M., Lachenal, N., Lahood, A, N, Lecca, L., Mazmanian, M., Mcilleron, H., Moreau, M., Moschioni, M., Nahid, P., Osso, E., Oyewusi, L., Panda, S., Pâquet, A., Thuong Huu, P., Pichon, L., Rich, M, L, Rupasinghe, P., Salahuddin, N., Sanchez Garavito, E., Seung, K, J, Velásquez, G, E, Vallet, M., Varaine, F., Yuya-Septoh, F, J, Mitnick, C, D, Guglielmetti, L.

المساهمون: Epicentre Paris Médecins Sans Frontières, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 1745-6215 ; Trials ; https://hal.science/hal-04328211Test ; Trials, 2023, 24 (1), pp.773. ⟨10.1186/s13063-023-07701-6⟩.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

العلاقة: hal-04328211; https://hal.science/hal-04328211Test; https://hal.science/hal-04328211/documentTest; https://hal.science/hal-04328211/file/Trials%202023_Guglielmetti.pdfTest

الإتاحة: https://doi.org/10.1186/s13063-023-07701-6Test
https://hal.science/hal-04328211Test
https://hal.science/hal-04328211/documentTest
https://hal.science/hal-04328211/file/Trials%202023_Guglielmetti.pdfTest

المؤلفون: Chabala, C, Wobudeya, E, van der Zalm, MM, Kapasa, M, Raichur, P, Mboizi, R, Palmer, M, Kinikar, A, Hissar, S, Mulenga, V, Mave, V, Musoke, P, Hesseling, AC, McIlleron, H, Gibb, D, Crook, A, Turkova, A, SHINE trial team

العلاقة: pii: 7642898; Chabala, C., Wobudeya, E., van der Zalm, M. M., Kapasa, M., Raichur, P., Mboizi, R., Palmer, M., Kinikar, A., Hissar, S., Mulenga, V., Mave, V., Musoke, P., Hesseling, A. C., McIlleron, H., Gibb, D., Crook, A., Turkova, A. & SHINE trial team, (2024). Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial. Clinical Infectious Diseases, https://doi.org/10.1093/cid/ciae193Test.; http://hdl.handle.net/11343/344698Test

الإتاحة: https://doi.org/10.1093/cid/ciae193Test
http://hdl.handle.net/11343/344698Test

المؤلفون: Turkova, A, Wills, GH, Wobudeya, E, Chabala, C, Palmer, M, Kinikar, A, Hissar, S, Choo, L, Musoke, P, Mulenga, V, Mave, V, Joseph, B, LeBeau, K, Thomason, MJ, Mboizi, RB, Kapasa, M, van der Zalm, MM, Raichur, P, Bhavani, PK, McIlleron, H, Demers, A-M, Aarnoutse, R, Love-Koh, J, Seddon, JA, Welch, SB, Graham, SM, Hesseling, AC, Gibb, DM, Crook, AM, SHINE Trial Team

العلاقة: Turkova, A., Wills, G. H., Wobudeya, E., Chabala, C., Palmer, M., Kinikar, A., Hissar, S., Choo, L., Musoke, P., Mulenga, V., Mave, V., Joseph, B., LeBeau, K., Thomason, M. J., Mboizi, R. B., Kapasa, M., van der Zalm, M. M., Raichur, P., Bhavani, P. K. ,. SHINE Trial Team, (2022). Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children. N Engl J Med, 386 (10), pp.911-922. https://doi.org/10.1056/NEJMoa2104535Test.; http://hdl.handle.net/11343/299903Test

الإتاحة: https://doi.org/10.1056/NEJMoa2104535Test
http://hdl.handle.net/11343/299903Test

المؤلفون: Abdelgawad, N, Chirehwa, M, Schutz, C, Barr, D, Ward, A, Janssen, S, Burton, R, Wilkinson, R, Shey, M, Wiesner, L, McIlleron, H, Maartens, G, Meintjes, G, Denti, P

المصدر: 20 ; 1

العلاقة: Wellcome Open Research; http://hdl.handle.net/10044/1/100647Test

الإتاحة: https://doi.org/10.12688/wellcomeopenres.17660.1Test
http://hdl.handle.net/10044/1/100647Test

المؤلفون: Savic, RM, Ruslami, R, Hibma, JE, Hesseling, A, Ramachandran, G, Ganiem, AR, Swaminathan, S, McIlleron, H, Gupta, A, Thakur, K, van Crevel, R, Aarnoutse, R, Dooley, KE

المصدر: Clinical Pharmacology & Therapeutics. 98(6)

مصطلحات موضوعية: Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Trials and Supportive Activities, Tuberculosis, Orphan Drug, Infectious Diseases, Pediatric, Clinical Research, Rare Diseases, Neurosciences, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Infection, Good Health and Well Being, Administration, Intravenous, Administration, Oral, Adolescent, Adult, Age Factors, Antitubercular Agents, Body Weight, Child, Child, Preschool, Clinical Trials, Phase II as Topic, Computer Simulation, Drug Dosage Calculations, Humans, Infant, Levofloxacin, Models, Biological, Mycobacterium tuberculosis, Randomized Controlled Trials as Topic, Rifampin, Tuberculosis, Meningeal, Pharmacology & Pharmacy, Pharmacology and pharmaceutical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/7140x91jTest

المؤلفون: Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, Emmanuel, Berikova, E., Bonnet, Maryline, Chang, E., Cloez, S., Coit, J., M., Cox, V., de Jong, B., C., Delifer, C., Do, J., M., Tozzi, D. dos Santos, Ducher, V., Ferlazzo, G., Gouillou, M., Khan, A., Khan, U., Lachenal, N., Lahood, A., N., Lecca, L., Mazmanian, M., Mcilleron, H., Moschioni, M., O'Brien, K., Okunbor, O., Oyewusi, L., Panda, S., Patil, S., B., Phillips, P., P. J., Pichon, L., Rupasinghe, P., Rich, M., L., Saluhuddin, N., Seung, K., J., Tamirat, M., Trippa, L., Cellamare, M., Velásquez, G., E., Wasserman, S., Zimetbaum, P., J., Varaine, F., Mitnick, C., D.

المساهمون: Médecins Sans Frontières Paris (MSF), Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institute of Tropical Medicine Antwerp (ITM), Epicentre Paris Médecins Sans Frontières, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I (UY1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Cheikh Anta Diop de Dakar Sénégal (UCAD), Harvard Medical School Boston (HMS), University of Cape Town, Médecins Sans Frontières Cape Town, South Africa, Centre d'investigation clinique Paris Est CHU Pitié Salpêtrière (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Abiomed SARL, Société Abiomed, National AIDS Research Institute, Indian Council of Medical Research New Dehli (ICMR), Brigham & Women’s Hospital Boston (BWH), The indus hospital Karachi, Pakistan, Dana-Farber Cancer Institute Boston, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center Boston (BIDMC), The trial and the preparation of this manuscript are funded by a grantprovided by Unitaid. The funding source had no role in the study design, inthe collection, management, analysis, or interpretation of data, in the writingof the report, or in the decision to submit the report for publication.GEV received funding from the National Institute of Allergy and InfectiousDiseases at the US National Institutes of Health (grant numbers K08AI141740, L30 AI120170, and P30 AI060354), the Dr. Lynne Reid/Drs. Eleanorand Miles Shore Fellowship at Harvard Medical School, the Burke GlobalHealth Fellowship at the Harvard Global Health Institute, and the HarvardUniversity Center for AIDS Research

المصدر: ISSN: 1745-6215 ; Trials ; https://hal.sorbonne-universite.fr/hal-03368536Test ; Trials, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩.

مصطلحات موضوعية: Bayesian adaptive randomization, Bedaquiline, Clofazimine, Delamanid, Fluoroquinolone, Linezolid, MDR-TB, Non-inferiority, Pyrazinamide, Rifampin-resistant tuberculosis, Treatment shortening, MESH: Antitubercular Agents, MESH: Bayes Theorem, MESH: Humans, MESH: Pharmaceutical Preparations, MESH: Randomized Controlled Trials as Topic, MESH: Rifampin, MESH: Tuberculosis, Multidrug-Resistant, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34563240; hal-03368536; https://hal.sorbonne-universite.fr/hal-03368536Test; https://hal.sorbonne-universite.fr/hal-03368536/documentTest; https://hal.sorbonne-universite.fr/hal-03368536/file/s13063-021-05491-3.pdfTest; PUBMED: 34563240; PUBMEDCENTRAL: PMC8465691; WOS: 000700766300003

الإتاحة: https://doi.org/10.1186/s13063-021-05491-3Test
https://hal.sorbonne-universite.fr/hal-03368536Test
https://hal.sorbonne-universite.fr/hal-03368536/documentTest
https://hal.sorbonne-universite.fr/hal-03368536/file/s13063-021-05491-3.pdfTest

المؤلفون: Chabala, C, Turkova, A, Hesseling, AC, Zimba, KM, van der Zalm, M, Kapasa, M, Palmer, M, Chirehwa, M, Wiesner, L, Wobudeya, E, Kinikar, A, Mave, V, Hissar, S, Choo, L, LeBeau, K, Mulenga, V, Aarnoutse, R, Gibb, D, McIlleron, H

المصدر: Clinical Infectious Diseases (2021) (In press).

مصطلحات موضوعية: pharmacokinetics, tuberculosis, antituberculosis drugs, children, dosing

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10135149/1/ciab725.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10135149Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10135149/1/ciab725.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10135149Test/

المؤلفون: Dheda, K, Gumbo, T, Maartens, G, Dooley, KE, McNerney, R, Murray, M, Furin, J, Nardell, EA, London, L, Lessem, E, Theron, G, van Helden, P, Niemann, S, Merker, M, Dowdy, D, Van Rie, A, Siu, GKH, Pasipanodya, JG, Rodrigues, C, Clark, TG, Sirgel, FA, Esmail, A, Lin, HH, Atre, SR, Schaaf, HS, Chang, KC, Lange, C, Nahid, P, Udwadia, ZF, Horsburgh, CR, Churchyard, GJ, Menzies, D, Hesseling, AC, Nuermberger, E, McIlleron, H, Fennelly, KP, Goemaere, E, Jaramillo, E, Low, M, Jara, CM, Padayatchi, N, Warren, RM

المصدر: The Lancet. Respiratory medicine. 5(4):291-360

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:135433552Test